Pricing Log in Create free account

CervoMed Inc. (CRVO) vs 4D pharma PLC Sponsored ADR (LBPS)

CervoMed Inc. and 4D pharma PLC Sponsored ADR are both Biotechnology companies. CervoMed Inc. and 4D pharma PLC Sponsored ADR are of similar size ($37.2M and $34.0M). CervoMed Inc. has the higher net margin (0.00% vs −2,010.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, CervoMed Inc. leads on 8 and 4D pharma PLC Sponsored ADR on 5.

Valuation

Metric CRVO LBPS Biotechnology median
P/E n/m n/m 8.50
P/S 5.73 211.23 9.71
P/B 1.00 9.49 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m — 0.64
EV/Sales 2.74 — 9.21
Earnings yield (143.75%) (40.76%) (33.15%)
Free cash flow yield (123.82%) (30.32%) (25.50%)

Profitability

Metric CRVO LBPS Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (2,010.89%) 0.00%
Free cash flow margin 0.00% (3,283.80%) 0.00%
Return on equity (107.62%) (155.83%) (56.36%)
Return on assets (94.73%) (77.95%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRVO LBPS Biotechnology median
Revenue growth (TTM) (58.86%) — 6.02%
EPS growth (last fiscal year) (47.52%) 35.04% 30.26%
Revenue growth, 5-year CAGR — 21.70% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRVO LBPS Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 8.57 5.21 4.72
Net debt to EBITDA 0.74 0.23 0.96

Dividend

Metric CRVO LBPS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRVO LBPS Biotechnology median
Market cap 34.02m 37.19m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack